NEUROCRINE BIOSCIENCES INC (NBIX) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2009: $35.0K2010: $315.0K2011: $750.0K2012: $971.0K2013: $545.0K2014: $1.61M2015: $1.93M2016: $4.11M2017: $6.94M2018: $24.80M2019: $14.70M2020: $10.90M2021: $23.40M2022: $16.50M2023: $28.30M2024: $38.20M2025: $34.00M$34.00M
2009Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$34.00M-11.0%
2024$38.20M+35.0%
2023$28.30M+71.5%
2022$16.50M-29.5%
2021$23.40M+114.7%
2020$10.90M-25.9%
2019$14.70M-40.7%
2018$24.80M+257.3%
2017$6.94M+68.9%
2016$4.11M+112.4%
2015$1.93M+20.0%
2014$1.61M+195.8%
2013$545.0K-43.9%
2012$971.0K+29.5%
2011$750.0K+138.1%
2010$315.0K+800.0%
2009$35.0K